Wai yi Zou

Summary

Country: China

Publications

  1. ncbi request reprint [Dynamic observations of beta-catenin in chronic myeloid leukemia and its relationship with cytogenetic response]
    Wai yi Zou
    Department of Hematology, First Affiliated Hospital of Sun Yat sen University, Guangzhou 510080, China
    Nan Fang Yi Ke Da Xue Xue Bao 30:1868-70, 1873. 2010
  2. ncbi request reprint [Therapeutic effects of imatinib on chronic myeloid leukemia in different phases and the factors affecting the effects]
    Wai yi Zou
    Department of Hematology, First Affiliated Hospital, Sun Yat Sen University, Guangzhou, China
    Nan Fang Yi Ke Da Xue Xue Bao 28:1660-2. 2008
  3. ncbi request reprint Sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation in patients with multiple myeloma
    Dong Zheng
    Department of Hematology, Sun Yat Sen University, Guangzhou, Guangdong, China
    Chin Med J (Engl) 125:4454-9. 2012
  4. ncbi request reprint [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia]
    Xiu zhen Tong
    Department of Hematology, the First Affiliated Hospital of Sun Yat Sen University, Guangzhou 510080, China
    Zhonghua Zhong Liu Za Zhi 28:545-8. 2006
  5. ncbi request reprint [The efficacy and safety of bortezomib-based induction regimen before autologous hematopoietic stem cell transplantation in patients with multiple myeloma]
    Juan Li
    Department of Hematology, The First Affiliated Hospital, Sun Yat Sen University, Guangzhou 510080, China
    Zhonghua Nei Ke Za Zhi 51:279-83. 2012
  6. ncbi request reprint [The clinical features of infection in multiple myeloma undergoing autologous hematopoietic stem cell transplantation]
    Juan Li
    Department of Hematology, First Affiliated Hospital of Sun Yat sen University, Guangzhou 510080, China
    Zhonghua Nei Ke Za Zhi 50:44-7. 2011
  7. doi request reprint [Clinical significance of abnormal protein bands in multiple myeloma treated with bortezomib-based induction regimen and autologous stem cell transplantation]
    He Hua Wang
    Department of Hematology, The First Affiliated Hospital, Sun Yat Sen University, Guangzhou, China
    Zhonghua Xue Ye Xue Za Zhi 34:327-31. 2013
  8. ncbi request reprint [Significance of sRANKL/OPG ratio in diagnosis of multiple myeloma bone disease]
    Duo Rong Xu
    Department of Hematology, The First Affiliated Hospital, Sun Yat Sen University, Guangzhou 510080, Guangdong Province, China
    Zhongguo Shi Yan Xue Ye Xue Za Zhi 18:376-80. 2010
  9. doi request reprint [Observation of humoral immunity reconstitution and its relationship with infection after autologous hematopoietic stem cell transplantation for patients with multiple myeloma]
    Jun Ru Liu
    Department of Hematology, Sun Yat Sen University, Guangzhou, China
    Zhonghua Xue Ye Xue Za Zhi 34:317-22. 2013
  10. doi request reprint New targets of PS-341: BAFF and APRIL
    Wuping Li
    Department of Hematology, The First Affiliated Hospital, Sun Yat Sen University, 58 Zhong Shan Road II, Guangzhou 510080, China
    Med Oncol 27:439-45. 2010

Collaborators

Detail Information

Publications14

  1. ncbi request reprint [Dynamic observations of beta-catenin in chronic myeloid leukemia and its relationship with cytogenetic response]
    Wai yi Zou
    Department of Hematology, First Affiliated Hospital of Sun Yat sen University, Guangzhou 510080, China
    Nan Fang Yi Ke Da Xue Xue Bao 30:1868-70, 1873. 2010
    ..To investigate the changes in the expression of beta-catenin in patients with chronic myeloid leukemia (CML) in different phases, and explore the relationship between beta-catenin and the cytogenetic response to imatinib mesylate...
  2. ncbi request reprint [Therapeutic effects of imatinib on chronic myeloid leukemia in different phases and the factors affecting the effects]
    Wai yi Zou
    Department of Hematology, First Affiliated Hospital, Sun Yat Sen University, Guangzhou, China
    Nan Fang Yi Ke Da Xue Xue Bao 28:1660-2. 2008
    ..To evaluate the therapeutic effect of imatinib on chronic myeloid leukemia (CML) in different phases and analyze the factors that may affect the effects...
  3. ncbi request reprint Sequential treatment with bortezomib plus dexamethasone followed by autologous hematopoietic stem cell transplantation in patients with multiple myeloma
    Dong Zheng
    Department of Hematology, Sun Yat Sen University, Guangzhou, Guangdong, China
    Chin Med J (Engl) 125:4454-9. 2012
    ..Our purpose was to assess the efficacy and adverse effects of sequential treatment with BD chemotherapy and ASCT in patients with multiple myeloma...
  4. ncbi request reprint [Effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation for chronic myelogenous leukemia]
    Xiu zhen Tong
    Department of Hematology, the First Affiliated Hospital of Sun Yat Sen University, Guangzhou 510080, China
    Zhonghua Zhong Liu Za Zhi 28:545-8. 2006
    ..To retrospectively analyze the curative effects and prognostic factors of HLA-matched sibling donor allogeneic hematopoietic stem cell transplantation (allo-HSCT) for chronic myelogenous leukemia patients (CML)...
  5. ncbi request reprint [The efficacy and safety of bortezomib-based induction regimen before autologous hematopoietic stem cell transplantation in patients with multiple myeloma]
    Juan Li
    Department of Hematology, The First Affiliated Hospital, Sun Yat Sen University, Guangzhou 510080, China
    Zhonghua Nei Ke Za Zhi 51:279-83. 2012
    ..To investigate the efficacy and safety of bortezomib-based induction regimen followed by autologous hematopoietic stem cell transplantation (ASCT) in patients with multiple myeloma (MM)...
  6. ncbi request reprint [The clinical features of infection in multiple myeloma undergoing autologous hematopoietic stem cell transplantation]
    Juan Li
    Department of Hematology, First Affiliated Hospital of Sun Yat sen University, Guangzhou 510080, China
    Zhonghua Nei Ke Za Zhi 50:44-7. 2011
    ..To explore the clinical features of infection in multiple myeloma (MM) undergoing autologous hematopoietic stem cell transplantation (ASCT)...
  7. doi request reprint [Clinical significance of abnormal protein bands in multiple myeloma treated with bortezomib-based induction regimen and autologous stem cell transplantation]
    He Hua Wang
    Department of Hematology, The First Affiliated Hospital, Sun Yat Sen University, Guangzhou, China
    Zhonghua Xue Ye Xue Za Zhi 34:327-31. 2013
    ..To study the clinical significance of abnormal protein bands (APB) in multiple myeloma (MM) patients treated with bortezomib-based induction regimen and autologous stem cell transplantation (ASCT)...
  8. ncbi request reprint [Significance of sRANKL/OPG ratio in diagnosis of multiple myeloma bone disease]
    Duo Rong Xu
    Department of Hematology, The First Affiliated Hospital, Sun Yat Sen University, Guangzhou 510080, Guangdong Province, China
    Zhongguo Shi Yan Xue Ye Xue Za Zhi 18:376-80. 2010
    ..In short, the sRANKL/OPG ratio can be used as a reference index for the diagnosis of MBD...
  9. doi request reprint [Observation of humoral immunity reconstitution and its relationship with infection after autologous hematopoietic stem cell transplantation for patients with multiple myeloma]
    Jun Ru Liu
    Department of Hematology, Sun Yat Sen University, Guangzhou, China
    Zhonghua Xue Ye Xue Za Zhi 34:317-22. 2013
    ..To study the humoral immunity reconstitution and its relationship with infection in patients with multiple myeloma (MM) after undergoing autologous hematopoietic stem cell transplantation (auto-HSCT)...
  10. doi request reprint New targets of PS-341: BAFF and APRIL
    Wuping Li
    Department of Hematology, The First Affiliated Hospital, Sun Yat Sen University, 58 Zhong Shan Road II, Guangzhou 510080, China
    Med Oncol 27:439-45. 2010
    ..In summary, PS-341 was shown to block this pathway. PS-341 inhibits the autocrine secretion of BAFF and APRIL and thereby MM cell proliferation by the alterative NF-kappaB2 pathway. BAFF and APRIL appear to be the targets of PS-341...
  11. ncbi request reprint [Influence of thalidomide on bone marrow microenvironment in refractory and relapsed multiple myeloma]
    Juan Li
    Department of Hematology, The First Affiliated Hospital, Sun Yat Sen University, Guangzhou, Guangdong, PRChina
    Ai Zheng 22:346-9. 2003
    ..This study was conducted to investigate the mechanism of thalidomide by observation of influence of thalidomide on bone marrow microenvironment in refractory and relapsed multiple myeloma...
  12. ncbi request reprint [Values of soluble thrombomodulin and von Willebrand factor judging reject reaction in liver transplantation]
    Chun guang Wen
    Department of Hematology, First Affiliated Hospital, Sun Yat Sen University, Guangzhou 510080, China
    Zhonghua Gan Zang Bing Za Zhi 11:295-7. 2003
    ..To find sensitive and specific laboratory examination items for early diagnosing and monitoring liver transplantation reject reaction...
  13. pmc Prophylactic antiviral therapy in allogeneic hematopoietic stem cell transplantation in hepatitis B virus patients
    Ya Ping Liao
    Ya Ping Liao, Jia Lu Jiang, Wai Yi Zou, Duo Rong Xu, Juan Li, Department of Hematology, The First Affiliated Hospital, Sun Yat Sen University, Guangzhou 510000, Guangdong Province, China
    World J Gastroenterol 21:4284-92. 2015
    ..To investigate the timing, safety and efficacy of prophylactic antiviral therapy in patients with hepatitis B virus (HBV) infection undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT)...
  14. ncbi request reprint [Efficacy and toxicity of intravenous busulfan-based conditioning before allogeneic peripheral blood stem cell transplantation for leukemia]
    Xiu zhen Tong
    Department of Hematology, The First Affiliated Hospital, Sun Yat Sen University, Guangzhou, Guangdong, 510080, PR China
    Ai Zheng 26:914-8. 2007
    ..This study was to analyze the efficacy and toxicity of intravenous Bu and cyclophosphamide (Cy) conditioning before allogeneic peripheral blood stem cell transplantation (allo-PBSCT) for leukemia...